Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anal cancer--current perspectives

P S Carter1

  • 1Imperial Cancer Research Fund, Colorectal Cancer Unit, St. Mark's Hospital, London, UK.

Digestive Diseases (Basel, Switzerland)
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes in 2748 patients referred to a colorectal two-week rule clinic.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2007
Same author

Complications of adjuvant radiotherapy for rectal cancer.

Surgical technology international·2002
Same author

The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.

Structure (London, England : 1993)·2001
Same author

A method for identification of inhibitors of the phosphorylation reactions of bacterial response regulator proteins using (31)P nuclear magnetic resonance spectroscopy.

Analytical biochemistry·2001
Same author

The aetiology and epidemiology of faecal incontinence.

Hospital medicine (London, England : 1998)·2001
Same author

The surgical management of faecal incontinence.

Hospital medicine (London, England : 1998)·2001
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Human papillomaviruses are linked to anal cancer, similar to cervical cancer. High-risk groups for anal cancer include immunosuppressed individuals and never-married men, necessitating a review of its causes and management.

Area of Science:

  • Oncology
  • Virology
  • Epidemiology

Background:

  • Anal cancer is a rare malignancy, comprising 2% of anorectal cancers.
  • Similarities between cervical and anal cancers suggest a common etiological agent.
  • Human papillomaviruses (HPVs) DNA is consistently found in both cancer types, implicating them in tumorigenesis.

Purpose of the Study:

  • To review the etiology, presentation, and management of anal cancer.
  • To address the potential increase in anal cancer cases.
  • To highlight changing demographics and identify high-risk populations.

Main Methods:

  • Literature review on anal cancer etiology and epidemiology.
  • Analysis of studies identifying risk factors and demographic trends.

Related Experiment Videos

  • Synthesis of information on HPV's role in anal carcinogenesis.
  • Main Results:

    • Human papillomaviruses are strongly implicated as a common etiological agent in anal cancer.
    • Epidemiological data suggests a changing demography of anal cancer.
    • High-risk groups identified include never-married men and immunosuppressed patients (transplant recipients, HIV-infected individuals).

    Conclusions:

    • The increasing prevalence of organ transplantation and HIV infection may lead to a rise in anal cancer cases.
    • A comprehensive understanding of anal cancer's etiology, presentation, and management is timely and crucial.
    • Further research and clinical attention are warranted for high-risk populations.